Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Sernova Corp | SVA | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.445 | 0.43 | 0.445 | 0.43 | 0.445 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
15 | 20,000 | - | 0.375 - 1.15 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:59:59 | 500 | $ 0.43 | CAD |
Sernova Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
130.43M | 303.33M | - | 0 | -39M | -0.13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sernova News
Date | Time | Source | News Article |
---|---|---|---|
5/03/2023 | 17:55 | Dow Jones News | ADRs End Mostly Lower; Sernova Gains on AstraZeneca.. |
5/03/2023 | 10:31 | Dow Jones News | Sernova Shares Jump With AstraZeneca Collaboration |
5/03/2023 | 06:53 | Dow Jones News | Sernova, AstraZeneca to Collaborate to Evaluate Potential.. |
4/25/2023 | 16:33 | PR Newswire (Canada) | Concerned Shareholders of Sernova Corp. Wish to Thank All.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SVA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.465 | 0.475 | 0.43 | 0.446388 | 67,873 | -0.035 | -7.53% |
1 Month | 0.54 | 0.60 | 0.375 | 0.477408 | 192,095 | -0.11 | -20.37% |
3 Months | 0.62 | 0.70 | 0.375 | 0.5422691 | 137,279 | -0.19 | -30.65% |
6 Months | 0.70 | 0.82 | 0.375 | 0.6173937 | 136,602 | -0.27 | -38.57% |
1 Year | 0.84 | 1.15 | 0.375 | 0.7159413 | 108,386 | -0.41 | -48.81% |
3 Years | 1.55 | 1.59 | 0.375 | 0.8739035 | 118,964 | -1.12 | -72.26% |
5 Years | 1.55 | 1.59 | 0.375 | 0.8739035 | 118,964 | -1.12 | -72.26% |
Sernova Description
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. |